Appistry Awards Inaugural Pipeline Challenge Prize to the Shivanand R. Patil Cytogenetics and Molecular Laboratory

Proposed next-generation sequencing (NGS) quality control pipeline will reduce costs and lower turnaround times for common genomics tests ST. LOUIS, MO (October 6, 2014) – Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, has selected the winner of its inaugural Appistry Pipeline Challenge. A project team led by Dr. Benjamin […]

Continue Reading →

Appistry Delivers Suite of Tools for Variant Annotation and Analysis

Integrated tools assist researchers with identifying variants of interest in next-generation sequencing (NGS) data ST LOUIS, MO (August 25, 2014) –Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, today announced the release of Variant Annotation and Analysis (VAA) Suite for identifying causal variants in next-generation sequencing (NGS) data. Building […]

Continue Reading →

Appistry Names Industry Experts to Judge Pipeline Challenge Competition

Panelists include the president of the NCGR and the bioinformatics director at Children’s Mercy, Kansas City ST LOUIS, MO (July 23, 2014) –Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, announced today its judging panel for the inaugural Appistry Pipeline Challenge. Two Appistry staff will be joined by Dr. […]

Continue Reading →

Appistry Announces Pipeline Challenge Competition to Reward Creative Solutions for NGS Analysis

Winner will receive $70,000 worth of bioinformatics tools, software, hardware, and support to develop and build a production-grade pipeline ST LOUIS, MO (July 8, 2014) –Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, today launched its inaugural Appistry Pipeline Challenge. The competition will provide $70,000 of software and hardware […]

Continue Reading →

Appistry Teams with Personal Genome Diagnostics to Offer CancerSelect™ Test through Appistry CloudDx™

Leading cancer genomics firm’s test panel that identifies key cancer mutations is now available nationwide as part of new cloud-based service for community physicians and regional hospitals CHICAGO (May 30, 2014) – Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, today announced an agreement with Personal Genome Diagnostics (PGDx) […]

Continue Reading →

Appistry Launches Cloud-based Service for Genomics Testing

Appistry CloudDx™ targets community physicians and regional hospitals to broaden access to established laboratory-developed tests (LDTs)  CHICAGO (May 30, 2014) – Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, announced today the launch of Appistry CloudDx™, a cloud-based service for ordering genomics tests. By collecting established laboratory-developed tests (LDTs) […]

Continue Reading →

Appistry Releases Commercial Version of Broad Institute’s GATK 3

First demonstrations of new functionality at annual AACR meeting in San Diego ST LOUIS, MO (April 3, 2014) – Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, today released the latest commercial version of the Broad Institute’s Genome Analysis Toolkit (GATK). GATK 3 provides new functionality and best practices to tackle modern challenges in next-generation […]

Continue Reading →

N-of-One and Appistry Partner to Provide Comprehensive, Affordable Genomic Sequencing Analysis and Interpretation Solutions

– Partnership Addresses the Analysis and Interpretation Hurdles That Limit the Impact of Precision Medicine – ST. LOUIS, Mo. and LEXINGTON, Mass., February 18, 2014 – Appistry, a leading provider of high-performance computing and analytics solutions for next-generation medicine, and N-of-One, the leading provider of molecular interpretation and therapeutic strategies for personalized medicine in cancer care, today announced a partnership […]

Continue Reading →

NIH and Appistry Partner to Implement Genetic Analysis Pipeline for Undiagnosed Diseases Program

Pipeline uses family genetics to identify the root causes of rare, unknown diseases ST. LOUIS, MO (January 22, 2014) – Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, is partnering with the Undiagnosed Diseases Program (UDP) at the National Institutes of Health (NIH) to implement a unique genetic-analysis pipeline for patient diagnosis. Assembled by the NIH […]

Continue Reading →

Appistry Expands Genetic Analysis Offerings Powered by Broad Institute Tools

Expanded partnership reflects need for validated, supported analysis tools for clinical sequencing workflows ST. LOUIS (December 2, 2013) – Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, announced the expansion of its Cancer Genome Analysis (CGA) Suite to include additional tools for next-generation sequencing (NGS) analysis from the Broad Institute. The first addition to the […]

Continue Reading →

Appistry Chief Scientific Officer to Speak at Inaugural Conference on Delivering Genome-Enabled Diagnostics in the Clinic

St. Louis, MO (SEPT. 23, 2013)—Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine and the authorized distributor of select genetic analysis tools from the Broad Institute, today announced its chief scientific officer, Dr. Richard Mazzarella, will deliver a presentation titled “Clinical Best Practices for Cancer Genetic Analysis Pipelines,” at Cambridge HealthTech Institute’s inaugural Clinical Genomics for Cancer […]

Continue Reading →

Appistry Launches Integrated Suite for Cancer Genome Analysis

Suite makes the Broad Institute’s MuTect available to for-profit researchers for the first time St. Louis, MO (July 24, 2013)—Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine and the authorized distributor of select genetic analysis tools from the Broad Institute, launched today an integrated suite of tools for analyzing next-generation sequencing (NGS) cancer genome data. In […]

Continue Reading →

Appistry Announces Partnership with LifeMap Sciences, a Subsidiary of BioTime

Agreement will integrate critical sources of genetic and disease information into Appistry’s next-generation sequencing (“NGS”) reports for clinicians Appistry, Inc., which provides a big-data computing environment that supports life-science and medical analytics and workflows, announced today a collaborative partnership and value-added reseller agreement with LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX). The intent of the partnership is […]

Continue Reading →

Appistry Releases New Version of the GATK

Version 2013.1 is the first official commercial release incorporating full support from Appistry St. Louis, MO–April 8, 2013–Appistry, a leading provider of big-data software solutions, announced today the availability of the first fully supported commercial release of the Broad Institute’s industry-standard NGS analysis software, the Genome Analysis Toolkit (GATK). The release marks the first official release of the software by Appistry, […]

Continue Reading →

Appistry Announces Promotional Pricing on GATK

Official Commercial Release of Premiere Software for Genetic Analysis Now Available December 17, 2012 (ST. LOUIS) – Appistry, a leading US-based provider of high-performance computing and analytics for managing and storing “big data,” announced today promotional pricing for the commercial version of the Broad Institute’s next generation Genome Analysis Toolkit (GATK). The promotional pricing coincides with the official commercial release […]

Continue Reading →

Leading Big Data Company Appistry Joins Genome Institute of Singapore to Accelerate Genomics in Asia

San Francisco (Nov. 28, 2012) – The Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) today announced the launch of a research collaboration with Appistry, a leading US-based provider ofhigh-performance computing and analytics for managing and storing “big data.” “We are excited about this collaboration as it leverages on our computational genomics platform,” said Professor Huck Hui NG, […]

Continue Reading →

Big Data Leader Appistry Rolls Out Broad Institute’s GATK 2

November 2, 2012 (St. Louis) – Appistry, a leader in private cloud computing and big data analysis, today announced availability of the pre-release of the commercial version of the Broad Institute’s next generation Genome Analysis Toolkit or GATK 2. GATK is the world’s most widely used software for data processing and variant calling of next-generation sequencing data used by bioinformatics professionals, biomedical researchers, and clinicians. Last month the Broad […]

Continue Reading →

Broad Institute Selects Appistry To Provide GATK 2.0 To For-Profit Users

FOR IMMEDIATE RELEASE   Broad Institute Selects Appistry To Provide GATK 2 To For-Profit Users License will include high-level customer support   Boston (Oct. 16, 2012) – The Broad Institute has selected St. Louis-based Appistry, Inc., to distribute to users at for-profit companies the world’s most widely used software for data processing and variant calling of next-generation sequencing data, the Genome […]

Continue Reading →